BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Di J, Pan J, Yu R, Teng Y, Cai Z, Deng X. The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis. Front Endocrinol (Lausanne) 2020;11:263. [PMID: 32477263 DOI: 10.3389/fendo.2020.00263] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Abdulateef DS. Correlation of serum prolactin with sleep duration, wake-up hour, and phases of the menstrual cycle in healthy adult subjects. Sleep Biol Rhythms 2023. [DOI: 10.1007/s41105-023-00448-2] [Reference Citation Analysis]
2 Niinuma SA, Lubbad L, Lubbad W, Moin ASM, Butler AE. The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature. IJMS 2023;24:1838. [DOI: 10.3390/ijms24031838] [Reference Citation Analysis]
3 Saei Ghare Naz M, Mousavi M, Mahboobifard F, Niknam A, Ramezani Tehrani F. A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome. Diagnostics (Basel) 2022;12. [PMID: 36552931 DOI: 10.3390/diagnostics12122924] [Reference Citation Analysis]
4 Emanuel RHK, Roberts J, Docherty PD, Lunt H, Campbell RE, Möller K. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1017468] [Reference Citation Analysis]
5 Niu J, Lu M, Liu B. Association between insulin resistance and abnormal menstrual cycle in Chinese patients with polycystic ovary syndrome.. [DOI: 10.21203/rs.3.rs-2171044/v1] [Reference Citation Analysis]
6 Zhang Y, Liu H. Cross-sectional association between prolactin levels and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a retrospective analysis of patients from a single hospital in China. BMJ Open 2022;12:e062252. [PMID: 36192106 DOI: 10.1136/bmjopen-2022-062252] [Reference Citation Analysis]
7 Kirsch P, Kunadia J, Shah S, Agrawal N. Metabolic effects of prolactin and the role of dopamine agonists: A review. Front Endocrinol 2022;13:1002320. [DOI: 10.3389/fendo.2022.1002320] [Reference Citation Analysis]
8 Macotela Y, Ruiz-herrera X, Vázquez-carrillo DI, Ramírez-hernandez G, Martínez de la Escalera G, Clapp C. The beneficial metabolic actions of prolactin. Front Endocrinol 2022;13:1001703. [DOI: 10.3389/fendo.2022.1001703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cunha L, Bonfim L, Lima G, Silva R, Silva L, Lima P, Oliveira-Bahia V, Freitas J, Burbano R, Rocha C. In vivo evaluation of the potential protective effects of prolactin against damage caused by methylmercury. Braz J Med Biol Res 2022;55:e11976. [PMID: 35857996 DOI: 10.1590/1414-431X2022e11976] [Reference Citation Analysis]
10 Mahboobifard F, Rahmati M, Amiri M, Azizi F, Ramezani Tehrani F. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study. Adv Med Sci 2022;67:79-86. [PMID: 34998115 DOI: 10.1016/j.advms.2021.12.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhu C, Ma H, Huang D, Li G, Gao J, Cai M, You H, Bu L, Qu S. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes. Front Endocrinol 2022;13:815995. [DOI: 10.3389/fendo.2022.815995] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pokorska-Niewiada K, Brodowska A, Brodowski J, Szczuko M. Levels of Trace Elements in Erythrocytes as Endocrine Disruptors in Obese and Nonobese Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health 2022;19:976. [PMID: 35055805 DOI: 10.3390/ijerph19020976] [Reference Citation Analysis]
13 Aljefri YE, Alahmadi RA, Alajmi RS, Alkhamisi TA, Maaddawi HA, Alraddadi AA, Alamri AM. Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center. Cureus 2021. [DOI: 10.7759/cureus.20593] [Reference Citation Analysis]
14 Purohit S, Rai S, Kalvit S. Prevalence of polycystic ovarian syndrome and its association with circulatory gonadotropins (luteinizing hormone and follicle-stimulating hormone) and prolactin in different reproductive age groups: A brief survey. JRHM 2021;2:8. [DOI: 10.25259/jrhm_27_2020] [Reference Citation Analysis]